SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-139355
Filing Date
2016-08-12
Accepted
2016-08-12 16:30:39
Documents
13
Period of Report
2016-08-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-16611_18k.htm 8-K 39328
2 EX-10.1 a16-16611_1ex10d1.htm EX-10.1 134342
3 EX-10.2 a16-16611_1ex10d2.htm EX-10.2 133862
4 EX-10.3 a16-16611_1ex10d3.htm EX-10.3 133466
5 EX-10.4 a16-16611_1ex10d4.htm EX-10.4 136333
6 EX-10.5 a16-16611_1ex10d5.htm EX-10.5 137178
7 EX-10.6 a16-16611_1ex10d6.htm EX-10.6 137258
8 GRAPHIC g166111ko01i001.jpg GRAPHIC 3486
9 GRAPHIC g166111km01i001.jpg GRAPHIC 3486
10 GRAPHIC g166111ks01i001.jpg GRAPHIC 3486
11 GRAPHIC g166111kq01i001.jpg GRAPHIC 3486
12 GRAPHIC g166111ku01i001.jpg GRAPHIC 3486
13 GRAPHIC g166111kw01i001.jpg GRAPHIC 3486
  Complete submission text file 0001104659-16-139355.txt   882866
Mailing Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY
Business Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37368 | Film No.: 161828614
SIC: 2836 Biological Products, (No Diagnostic Substances)